Trial 0C-20-13


A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Intravenous Zotatifin (eFT226) in Subjects with SelectedAdvanced Solid Tumor Malignancies

Type: Treatment
Phase: Phase I/II
Status: Open to Accrual
Treatments: Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Yan Ning, D.M., Cristina De Leon, Coordinator, Lorraine Martinez, Coordinator, Chi Nguyen, Coordinator, Leila Andres, Coordinator, Nicole Jensen, Coordinator, Xiomara Menendez, Coordinator, Jessica Levano, Coordinator, Arthur Alvarez, D.M., Khatchik Karakozian, D.M., Atessa Kiani, Coordinator, Negeen Izadian, Coordinator, Cristina Lee, Coordinator, Stephanie Kim, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.